Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?

Pennings JL, Kuc S, Rodenburg W, Koster MP, Schielen PC, de Vries A (2011) Integrative data mining to identify novel candidate serum biomarkers for preeclampsia screening. Prenat Diagn 31(12):1153–1159

Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GH, Schielen PC (2011) Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 66(4):225–239

Crispi F, Dominguez C, Liurba E, Martin-Gallan P, Cabero L, Gratacos E (2006) Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 195:201–207

Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E (2008) Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 31:303–309

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu K (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683

Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee KY, Goncalves LF (2004) Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Am J Obstet Gynecol 190:1541–1547

Andraweera PH, Dekker GA, Roberts CT (2012) The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update 18(4):436–457

Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH (2010) Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–13 weeks. Ultrasound Obstet Gynecol 35(6):662–670

Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E (2010) Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol 203(4): 383.e1-8

Wortelboer EJ, Koster MP, Cuckle HS, Stoutenbeek PH, Schielen PC, Visser GH (2010) First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early onset preeclampsia. BJOG 117(11):1384–1389

Unal ER, Robinson CJ, Johnson DD, Chang EY (2007) Second-trimester angiogenic factors as biomarkers for future onset preeclampsia. Am J Obstet Gynecol 197(2): 211.e1-4

De Vivo A, Baveira G, Giordano D, Todarello G, Corrado F, D’anna R (2008) Endoglin, PlGF and sFlt-1 as markers for predicting preeclampsia. Acta Obstet Gynecol Scand 87(8):837–842

Diab AE, El-Behery MM, Ebraheim MA, Shehata AE (2008) Angiogenic factors for the prediction of preeclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet 102(2):146–151

Lambert- Messeriian GM, Palomaki GE, Neveux LM, Chien E, Friedman A (2009) Early onset preeclampsia and second trimester serum markers. Prenat Diagn 29(12):1109–1117

Mishra D, Singh HP (2003) Kuppuswamy’s socioeconomic status scale—a revision. Indian J Pediatr 70(3):273–274

Davey DA, MacGillivray I (1988) The classification and definition of hypertensive disorders of pregnancy. Am J Obstet Gynecol 158:892–898

Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R (2000) Preeclampsia and fetal growth. Obstet Gynecol 96:950–955

MacKay AP, Berg CJ, Atrash HK (2001) Pregnancy related mortality from preeclampsia and eclampsia. Obstet Gynecol 97:533–538

Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B (2003) The frequency and severity of placental findings in women with preeclampsia and gestational age dependent. Am J Obstet Gynecol 189:1173–1177

Sebire NJ, Goldin RD, Regan L (2005) Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol 25:117–118

Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592–1594

Rasmussen S, Irgens LM (2003) Fetal growth and body proportion in preeclampsia. Obstet Gynecol 101:575–583

Aardema MW, Saro MC, Lander M, De Wolf BT, Oosterhof H, Aarnoudse JG (2004) Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities? Clin Sci (Lond) 106:377–382

Smith GC, Wear H (2009) The perinatal implications of angiogenic factors. Curr Opin Obstet Gynecol 21(2):111–116

Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Goncalves LF (2007) Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 196(4):326.e1–326.e13

Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E (2009) A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 22(11):1021–1038

Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H (2008) A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble VEGF receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small-for-gestational-age neonate. J Matern Fetal Med 21(1):9–23

Wulff C, Wilson H, Dickson SE, Wiegand SJ, Fraser HM (2002) Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy. Biol Reprod 66:802–812

Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389–395

Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242–248

Pijnenborg R, Robertson WB, Brosens I, Dixon G (1981) Trophoblast invasion and the establishment of hemochorial placentation in man and laboratory animals. Placenta 2:71–91

Gerretsen G, Huisjes HJ, Elema JD (1981) Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. BJOG 88:876–881

Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mortl M, Beckmann MW (2007) Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 29:407–413

Khaliq A, Dun KC, Jiang J, Shams M, Li XF (1999) Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor estimation: molecular evidence for “placental hypoxia’ in intrauterine growth restriction. Lab Invest 79(2):151–170

Nagamatsu T, Fujii T, Kusumi M, Zou L, Yamashita T, Osuga Y (2004) Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145:4838–4845

Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS (1997) Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 18:657–665

Gomez O, Figueras F, Martinez JM, Del Rio M, Palacio M, Eixarch E (2006) Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol 28:802–808

Kurdi W, Fayyad A, Thakur V, Harrington K (2004) Delayed normalization of uterine artery Doppler waveforms is not a benign phenomenon. Eur J Obstet Gynecol Reprod Biol 117:20–23

Hafner E, Schuchter K, Metzenbauer M, Philipp K (2000) Uterine artery Doppler perfusion in the first and second pregnancies. Ultrasound Obstet Gynecol 16:625–629

Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS (2001) Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 184:1267–1272

Erez O, Romero R, Espinoza J et al (2008) The change in concentrations of angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent of preeclampsia and SGA. J Matern Fetal Neonatal Med 21(5):279–287

Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E (2011) Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med 24(10):1187–1207

Ness RB, Roberts JM (1996) Heterogenous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175:1365–1370